OrphoMed: OrphoMed Announces Formation of Scientific Advisory Board

(marketscreener.com) SAN FRANCISCO, Dec. 18, 2018 /PRNewswire/ -- OrphoMed, Inc., a clinical-stage biopharmaceutical company developing first-in-class dimer therapeutics, announced today the formation of a Scientific Advisory Board (SAB) comprised of six experts in gastrointestinal disorders and drug discovery and development, who are faculty at world-leading...http://www.marketscreener.com/news/OrphoMed-Announces-Formation-of-Scientific-Advisory-Board--27769205/?utm_medium=RSS&utm_content=20181218